Skip to main content
Clinical Trials/JPRN-UMIN000020372
JPRN-UMIN000020372
Completed
未知

A study for evaluating the effects of oral intake of lactic acid bacteria on immune function after exercise. A randomized, double-blind, placebo- controlled trial. - A study for evaluating the effects of oral intake of lactic acid bacteria on immune function after exercise.

Juntendo University Graduate School of Medicine0 sites70 target enrollmentJuly 1, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
one (Healthy adults)
Sponsor
Juntendo University Graduate School of Medicine
Enrollment
70
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Juntendo University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Individuals who can\&\#39;t stop drinking for 2 days before the days of screening and checkup. 2\)Individuals who can\&\#39;t stop eating foods containing lactic acid bacteria and/or oligosaccharide, fermented foods during this study. 3\)Individuals who can\&\#39;t stop eating functional foods which may affect immune functions. 4\)Individuals who have a history of irritable bowel syndrome and Crohn\&\#39;s disease. 5\) Individuals who have a medical history of serious disease (e.g., diabetes, liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder. 6\)Individuals who have chronic diseases and use medicines continuously. 7\)Individuals who have under treatment or a history of drug addiction and/or alcoholism. 8\)Individuals who are judged as unsuitable for this study based on the results of blood test. 9\)Individuals with excessive alcohol\-drinking behaviors. 10\)Individuals who have a medical history of diseases affecting digestion and absorption. 11\)Individuals who are pregnant, breastfeeding, or planning to be pregnant in the near future. 12\)Individuals who are participating or willing to participate in other clinical trials. 13\)Individuals whose family works for a company manufacturing or selling healthy foods or functional foods. 14\)Individuals with steroid treatment. 15\)Individuals who are seropositive against HBV antigen, HCV antibody, HIV antibody, or HTLV\-1 antibody. 16\)Individuals who are judged unsuitable for this study by the investigator for other reasons.

Outcomes

Primary Outcomes

Not specified

Similar Trials